News
News from us and our partners
Tags
Topics
0 results
- News
Asceneuron secures $100 million Series C financing to advance ground breaking therapeutics in neurodegenerative diseases
- News
CEO spotlight: Thierry Abribat's third straight win
- News
Abivax provides operational and key program update
- News
AstraZeneca closes acquisition of Amolyt Pharma
- News
Sensorion announces new positive secondary efficacy endpoints data from SENS-401 Phase 2a clinical trial for the preservation of residual hearing loss
- News
Bioptimus launches H-optimus-0, the world's largest open-source AI foundation model for pathology
- News
HighLife welcomes Stefan Pilz as new Chief Executive Officer
- News
Myricx Bio announces Board Changes
- News
Mainstay Medical announces receipt of European and Australian approvals of MRI labeling on ReActiv8® Restorative Neurostimulation System™
- News
Afyren's fermentation lab reaches 2-million-hour-mark as it identifies new raw materials to fuel industrial expansion
- News
Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal
- News
Myricx Bio announces £90m ($114m) Series A financing to advance its novel NMTi-ADC therapeutics into clinical development
- News
Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
- News
Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325
- News
Sitryx announces leadership transition